Literature DB >> 21717908

Targeting IGF-1R: at a crossroad.

Adrian V Lee1, Douglas Yee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21717908      PMCID： PMC3925073     

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN： 0890-9091            Impact factor:   2.990


× No keyword cloud information.
  12 in total

1.  Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy.

Authors:  Danielle B Ulanet; Dale L Ludwig; C Ronald Kahn; Douglas Hanahan
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

2.  Development of an integrated genomic classifier for a novel agent in colorectal cancer: approach to individualized therapy in early development.

Authors:  Todd M Pitts; Aik Choon Tan; Gillian N Kulikowski; John J Tentler; Amy M Brown; Sara A Flanigan; Stephen Leong; Christopher D Coldren; Fred R Hirsch; Marileila Varella-Garcia; Christopher Korch; S Gail Eckhardt
Journal:  Clin Cancer Res       Date:  2010-06-08       Impact factor: 12.531

3.  Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells.

Authors:  F Frasca; G Pandini; P Scalia; L Sciacca; R Mineo; A Costantino; I D Goldfine; A Belfiore; R Vigneri
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

Review 4.  Insulin, insulin resistance, obesity, and cancer.

Authors:  Emily Jane Gallagher; Derek LeRoith
Journal:  Curr Diab Rep       Date:  2010-04       Impact factor: 4.810

5.  High IGF-IR activity in triple-negative breast cancer cell lines and tumorgrafts correlates with sensitivity to anti-IGF-IR therapy.

Authors:  Beate C Litzenburger; Chad J Creighton; Anna Tsimelzon; Bonita T Chan; Susan G Hilsenbeck; Tao Wang; Joan M Carboni; Marco M Gottardis; Fei Huang; Jenny C Chang; Michael T Lewis; Mothaffar F Rimawi; Adrian V Lee
Journal:  Clin Cancer Res       Date:  2010-12-22       Impact factor: 12.531

6.  Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial.

Authors:  Kathy S Albain; William E Barlow; Peter M Ravdin; William B Farrar; Gary V Burton; Steven J Ketchel; Charles D Cobau; Ellis G Levine; James N Ingle; Kathleen I Pritchard; Allen S Lichter; Daniel J Schneider; Martin D Abeloff; I Craig Henderson; Hyman B Muss; Stephanie J Green; Danika Lew; Robert B Livingston; Silvana Martino; C Kent Osborne
Journal:  Lancet       Date:  2009-12-10       Impact factor: 79.321

7.  Sequencing of type I insulin-like growth factor receptor inhibition affects chemotherapy response in vitro and in vivo.

Authors:  Xianke Zeng; Deepali Sachdev; Hua Zhang; Martine Gaillard-Kelly; Douglas Yee
Journal:  Clin Cancer Res       Date:  2009-04-07       Impact factor: 12.531

8.  Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes.

Authors:  Ruslan Novosyadlyy; Danielle E Lann; Archana Vijayakumar; Anne Rowzee; Deborah A Lazzarino; Yvonne Fierz; Joan M Carboni; Marco M Gottardis; Patricia A Pennisi; Alfredo A Molinolo; Naamit Kurshan; Wilson Mejia; Stefania Santopietro; Shoshana Yakar; Teresa L Wood; Derek LeRoith
Journal:  Cancer Res       Date:  2010-01-12       Impact factor: 12.701

9.  The mechanisms of differential sensitivity to an insulin-like growth factor-1 receptor inhibitor (BMS-536924) and rationale for combining with EGFR/HER2 inhibitors.

Authors:  Fei Huang; Ann Greer; Warren Hurlburt; Xia Han; Rameh Hafezi; Gayle M Wittenberg; Karen Reeves; Jiwen Chen; Douglas Robinson; Aixin Li; Francis Y Lee; Marco M Gottardis; Edwin Clark; Lee Helman; Ricardo M Attar; Ashok Dongre; Joan M Carboni
Journal:  Cancer Res       Date:  2009-01-01       Impact factor: 12.701

10.  Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma.

Authors:  Sofia Avnet; Laura Sciacca; Manuela Salerno; Giovanni Gancitano; Maria Francesca Cassarino; Alessandra Longhi; Mahvash Zakikhani; Joan M Carboni; Marco Gottardis; Armando Giunti; Michael Pollak; Riccardo Vigneri; Nicola Baldini
Journal:  Cancer Res       Date:  2009-03-03       Impact factor: 12.701
View more
  11 in total

Review 1.  Targeting the insulin-like growth factor receptor: developing biomarkers from gene expression profiling.

Authors:  David N Boone; Adrian V Lee
Journal:  Crit Rev Oncog       Date:  2012

Review 2.  Targeting insulin and insulin-like growth factor signaling in breast cancer.

Authors:  Yuzhe Yang; Douglas Yee
Journal:  J Mammary Gland Biol Neoplasia       Date:  2012-10-10       Impact factor: 2.673

3.  Quantifying insulin receptor isoform expression in FFPE breast tumors.

Authors:  Sean C Harrington; S John Weroha; Carol Reynolds; Vera J Suman; Wilma L Lingle; Paul Haluska
Journal:  Growth Horm IGF Res       Date:  2012-04-30       Impact factor: 2.372

4.  Growth hormone potentiates 17β-estradiol-dependent breast cancer cell proliferation independently of IGF-I receptor signaling.

Authors:  Dana L Felice; Lamiaa El-Shennawy; Shuangping Zhao; Daniel L Lantvit; Qi Shen; Terry G Unterman; Steven M Swanson; Jonna Frasor
Journal:  Endocrinology       Date:  2013-06-19       Impact factor: 4.736

5.  Metformin and an insulin/IGF-1 receptor inhibitor are synergistic in blocking growth of triple-negative breast cancer.

Authors:  Lei Xue; Fengju Chen; Fei Yue; Laura Camacho; Sushma Kothapalli; Guanyun Wei; Shixia Huang; Qianxing Mo; Fei Ma; Yi Li; Sao Jiralerspong
Journal:  Breast Cancer Res Treat       Date:  2020-09-17       Impact factor: 4.872

6.  Integrative analysis of common neurodegenerative diseases using gene association, interaction networks and mRNA expression data.

Authors:  Yu Liu; Mehmet Koyutürk; Sean Maxwell; Zhongming Zhao; Mark R Chance
Journal:  AMIA Jt Summits Transl Sci Proc       Date:  2012-03-19

Review 7.  Role of IGF1R in Breast Cancer Subtypes, Stemness, and Lineage Differentiation.

Authors:  Susan M Farabaugh; David N Boone; Adrian V Lee
Journal:  Front Endocrinol (Lausanne)       Date:  2015-04-24       Impact factor: 5.555

Review 8.  Epithelial-to-mesenchymal transition in breast cancer: a role for insulin-like growth factor I and insulin-like growth factor-binding protein 3?

Authors:  Hanna A Zielinska; Amit Bahl; Jeff Mp Holly; Claire M Perks
Journal:  Breast Cancer (Dove Med Press)       Date:  2015-01-19

9.  ImmunoPET Imaging of Insulin-Like Growth Factor 1 Receptor in a Subcutaneous Mouse Model of Pancreatic Cancer.

Authors:  Christopher G England; Anyanee Kamkaew; Hyung-Jun Im; Hector F Valdovinos; Haiyan Sun; Reinier Hernandez; Steve Y Cho; Edward J Dunphy; Dong Soo Lee; Todd E Barnhart; Weibo Cai
Journal:  Mol Pharm       Date:  2016-04-26       Impact factor: 4.939

10.  Validation of the Cancer BioChip System as a 3D siRNA screening tool for breast cancer targets.

Authors:  Joie N Marhefka; Rula A Abbud-Antaki
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.